|
Powered by Cell Signaling Technology |
Site Information |
---|
RSAIRRAstIEMPQQ SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 448114 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Kinases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on PLB: | |
Inhibit interaction with: |
References | |
---|---|
El-Armouche A, et al. (2007) Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol 43, 223-9
17560599 Curated Info |
|
Chen Z, Akin BL, Jones LR (2007) Mechanism of reversal of phospholamban inhibition of the cardiac Ca2+-ATPase by protein kinase A and by anti-phospholamban monoclonal antibody 2D12. J Biol Chem 282, 20968-76
17548345 Curated Info |
|
Mishra S, Sabbah HN, Jain JC, Gupta RC (2003) Reduced Ca2+-calmodulin-dependent protein kinase activity and expression in LV myocardium of dogs with heart failure. Am J Physiol Heart Circ Physiol 284, H876-83
12424092 Curated Info |
|
Mayer EJ, Huckle W, Johnson RG, McKenna E (2000) Characterization and quantitation of phospholamban and its phosphorylation state using antibodies. Biochem Biophys Res Commun 267, 40-8
10623571 Curated Info |
|
Mayer EJ, Savage GM, Johnson RG (1998) A quantitative immunoassay for the measurement of phospholamban levels and phosphorylation states. Measurement of phospholamban levels in transgenic mouse hearts. Ann N Y Acad Sci 853, 284-7
10603960 Curated Info |
|
Simmerman HK, et al. (1986) Sequence analysis of phospholamban. Identification of phosphorylation sites and two major structural domains. J Biol Chem 261, 13333-41
3759968 Curated Info |